SUCCESSFUL TENOFOVIR TREATMENT FOR FULMINANT HEPATITIS B INFECTION IN AN INFANT

被引：15

作者：

Diamanti, Antonella ^{[1
,4
]}

Sartorelli, Maria Rita ^{[1
,4
]}

Alterio, Arianna ^{[1
,4
]}

Comparcola, Donatella ^{[1
,4
]}

Corsetti, Tiziana ^{[2
]}

Iacono, Anna ^{[2
]}

Pizzichemi, Giuseppe ^{[3
]}

Nobili, Valerio ^{[1
,4
]}

de Goyet, Jean de Ville ^{[1
,4
]}

Torre, Guiliano ^{[1
,4
]}

机构：

[1] Bambino Gesu Children Hosp, Transplantat Ctr, I-00165 Rome, Italy

[2] Bambino Gesu Children Hosp, Hosp Pharm Unit, I-00165 Rome, Italy

[3] Bambino Gesu Children Hosp, Microbiol Unit, I-00165 Rome, Italy

[4] Bambino Gesu Children Hosp, Liver Unit, I-00165 Rome, Italy

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2011年 / 30卷 / 10期

关键词：

fulminant liver failure; hepatitis B; infant; tenofovir; LAMIVUDINE TREATMENT; CHILDREN; THERAPY; FAILURE; VACCINATION; CARRIER; SAFETY; AREAS; BORN;

D O I：

10.1097/INF.0b013e31821e23b3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Fulminant hepatic failure is defined by the presence of severe impairment of liver function, with or without encephalopathy, in patients with no underlying chronic liver disease. We report the case of a 4-month-old infant who developed fulminant hepatitis B infection and recovered concomitant with tenofovir therapy without liver transplantation.

引用

页码：912 / 914

页数：3

共 50 条

[41] The Conundrum of Lamivudine and Tenofovir Disoproxil Fumarate for Hepatitis B: Fetus Versus Infant
Rosenthal, Philip
[J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 279 - 280
[42] Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
Sarrecchia, C.
Svicher, V.
Volpi, A.
Salpini, R.
Ceccarelli, L.
Sordillo, P.
Bertoli, A.
Perno, C. F.
Andreoni, M.
[J]. INFECTION, 2011, 39 (04) : 367 - 370
[43] Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
C. Sarrecchia
V. Svicher
A. Volpi
R. Salpini
L. Ceccarelli
P. Sordillo
A. Bertoli
C. F. Perno
M. Andreoni
[J]. Infection, 2011, 39 : 367 - 370
[44] Relevance of hepatitis B surface antigen levels in patients with chronic hepatitis B during 5 year of tenofovir treatment
Singh, A. K.
Sharma, M. K.
Hissar, S. S.
Gupta, E.
Sarin, S. K.
[J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 (06) : 439 - 446
[45] Are teenagers aware of the risk of a hepatitis B virus infection as a sexually transmitted disease?
Jeffe, K. K.
Deterding, K.
Hueppe, M. K.
Jeffe, F.
Feyerabend, S.
Potthoff, A.
Manns, M. P.
Wedemeyer, H.
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (05) : 477 - +
[46] Analysis of Hepatitis B Virus Genotype Changes in Patients with Chronic Hepatitis B Infection on Tenofovir Therapy
Chauhan, Ranjit
Singh, Avishek K.
Rooge, Sheetalnath
Varshney, Aditi
Kumar, Manoj
Sarin, Shiv K.
[J]. JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (08) : 1364 - 1375
[47] Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
Richardson, D
Lamba, H
[J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (03) : 204 - 205
[48] Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection
Tufano, M.
Liccardo, D.
Riva, S.
Candusso, M.
Torre, G.
Iorio, R.
[J]. TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (02) : E81 - E84
[49] Fulminant Clostridioides difficile infection in an infant
Yamamura, Yoshiko
Ohhira, Tomoko
Ishii, Shigeki
Nakatani, Keigo
Nagata, Kouji
[J]. PEDIATRICS INTERNATIONAL, 2020, 62 (12) : 1401 - 1403
[50] Tenofovir alafenamide for hepatitis B: evolution or revolution?
Brouwer, Willem P.
[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03): : 174 - 175

← 1 2 3 4 5 →